![]() Spero Therapeutics Spero Therapeutics is a biopharmaceutical company developing a pipeline of novel treatments for bacterial infections. | ![]() EnClear Therapies EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases. | ![]() Respicardia Respicardia develops implantable therapies to improve respiratory and cardiovascular health. | ||
Founding Date | Founding Date 2013 | Founding Date 2018 | Founding Date 2018 | Founding Date 2006 |
Type | Type Public | Type Private | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Cambridge, US HQ | Locations Newburyport, US HQ | Locations HQ | Locations Hopkins, US HQ |
Employees | Employees 5739% increase | Employees 11 | Employees 405% decrease | Employees 94 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 10m (over 6 years ago) | Latest funding round $ 1.7m (about 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 121.5m | Total funding raised $ 12m | Total funding raised $ 1.7m | Total funding raised $ 149.1m |

EnClear Therapies is a company that develops a medical device designed for the treatment of neurological diseases.
View company
MicrofluidX is a company that develops cell bioprocessing technology.
View company
Respicardia develops implantable therapies to improve respiratory and cardiovascular health.
View company